A Sydney beautician has resolved her action seeking to set aside a bankruptcy notice filed by her alleged former lover, WiseTech Global boss Richard White.
Care A2 is set to miss the trial in its trade mark fight with rival A2 Milk after the baby formula company was ditched by its lawyers at Ashurst days ago.
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
Bix Six firm Ashurst has dropped Care A2 as a client on the eve of trial in the dairy company’s long-running battle to quash rival A2 Milk’s trade marks.
Nuix has taken a slew of insurers to court seeking coverage of legal bills incurred in defending multiple class actions and proceedings by the Australian Securities and Investments Commission.
A court has given “little weight” to submissions by a migration lawyer who used ChatGPT to generate notes on sections of the Migration Act, saying free AI tools are not of any “persuasive importance”.
Shareholders in lending platform Marketlend can bring a derivative suit against its directors for allegedly misusing company funds, including spending $1.3 million on barrister chambers fees.
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
A Sleeping Duck shareholder has been ordered to pay the company’s costs on an indemnity basis in its failed oppression suit, with a judge finding that its decisions to reject Sleeping Duck’s buy-out offers of roughly $4 million were unreasonable.
A PricewaterhouseCoopers partner has reached a settlement in a case alleging she was involved in a $3.3 million scheme to defraud her husband’s employer.